A new study published in the Journal of Clinical Immunology reveals that researchers at Children's Hospital of Wisconsin Research Institute and Medical College of Wisconsin have developed a new treatment for patients with primary immunodeficiency, known as common variable immunodeficiency (CVID), who have a potentially fatal lung disease. Common variable immunodeficiency (CVID) is the most common primary immunodeficiency that requires regular treatment with medication, ...Sunday 2 September 2012
New Treatment Method for Immunodeficient Patients With Potentially Fatal Lung Disease
A new study published in the Journal of Clinical Immunology reveals that researchers at Children's Hospital of Wisconsin Research Institute and Medical College of Wisconsin have developed a new treatment for patients with primary immunodeficiency, known as common variable immunodeficiency (CVID), who have a potentially fatal lung disease. Common variable immunodeficiency (CVID) is the most common primary immunodeficiency that requires regular treatment with medication, ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment